Civitas Therapeutics Gets $20M In Series A Financing
Civitas Therapeutics Inc. secured $20 million for its Series A financing. Founding investor Longitude Capital, along with co-lead Canaan Partnersof Westport, Conn., participated in the round. Civitas is a Chelsea, Mass.-based biopharmaceutical company that develops transformative pulmonary delivery therapies. It plans to use proceeds to advance its lead program for treating patients with Parkinson’s disease through clinical proof-of-concept.
10 January 2011•4 mins read
